IRIS Institutional Research Information System - OPENBS Open Archive UniBS

VITA, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.077
EU - Europa 5.475
AS - Asia 2.252
Continente sconosciuto - Info sul continente non disponibili 35
OC - Oceania 24
SA - Sud America 14
AF - Africa 4
Totale 22.881
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.035
CN - Cina 2.039
UA - Ucraina 1.963
IT - Italia 1.212
DE - Germania 645
IE - Irlanda 377
GB - Regno Unito 314
PL - Polonia 311
FI - Finlandia 228
FR - Francia 163
IN - India 107
SE - Svezia 98
BE - Belgio 86
CA - Canada 40
EU - Europa 29
TR - Turchia 29
AU - Australia 23
VN - Vietnam 22
IR - Iran 17
NL - Olanda 13
RU - Federazione Russa 10
CH - Svizzera 9
AT - Austria 8
BR - Brasile 7
ES - Italia 7
HK - Hong Kong 7
HU - Ungheria 6
RO - Romania 6
A1 - Anonimo 5
SA - Arabia Saudita 5
JP - Giappone 4
MU - Mauritius 4
AR - Argentina 3
BD - Bangladesh 3
GR - Grecia 3
ID - Indonesia 3
SI - Slovenia 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
BG - Bulgaria 2
CZ - Repubblica Ceca 2
EE - Estonia 2
LA - Repubblica Popolare Democratica del Laos 2
SG - Singapore 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
CL - Cile 1
EC - Ecuador 1
FK - Isole Falkland (Malvinas) 1
HR - Croazia 1
IM - Isola di Man 1
IS - Islanda 1
JO - Giordania 1
KR - Corea 1
KW - Kuwait 1
LB - Libano 1
LU - Lussemburgo 1
MS - Montserrat 1
MX - Messico 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 22.881
Salva come PNG Salva come JPEG
Città #
Fairfield 2.157
Woodbridge 1.770
Jacksonville 1.524
Houston 1.275
Chandler 1.125
Ashburn 867
Cambridge 848
Seattle 827
Ann Arbor 801
Wilmington 776
Princeton 720
Nanjing 503
Dublin 373
Warsaw 311
Brescia 298
Beijing 222
Nanchang 180
Des Moines 157
Dearborn 154
Changsha 143
Shenyang 132
Hebei 122
Lancaster 122
Jinan 120
Tianjin 118
San Diego 105
Milan 100
Helsinki 97
Jiaxing 80
Brussels 74
Hangzhou 59
London 57
Zhengzhou 52
Kunming 50
San Mateo 47
Rome 46
Washington 41
Ningbo 33
Norwalk 33
Toronto 33
Lanzhou 31
Augusta 30
Orange 30
San Francisco 30
Haikou 29
Guangzhou 28
Leawood 28
Boardman 27
Taizhou 26
Verona 23
Dong Ket 22
Kocaeli 21
Monmouth Junction 18
Taiyuan 18
Fuzhou 16
Redwood City 16
Ardabil 14
Changchun 14
Bologna 12
Gent 11
Mumbai 10
Lappeenranta 9
Mantova 9
Melbourne 9
New Bedfont 9
Cagliari 8
Canberra 8
Chiswick 7
Poncarale 7
Bolzano 6
Frankfurt am Main 6
Hefei 6
Islington 6
Pavia 6
Reggio Calabria 6
Reggio Nell'emilia 6
Rozzano 6
Sesto San Giovanni 6
Castellanza 5
Castiglione delle Stiviere 5
Falkenstein 5
Florence 5
Hanover 5
Morbegno 5
Neumarkt 5
New York 5
Palermo 5
Piacenza 5
Rezzato 5
Roccafranca 5
Tulsa 5
Turin 5
Vigevano 5
Walnut 5
Bari 4
Bergamo 4
Como 4
Flero 4
Guidonia 4
Naples 4
Totale 17.230
Salva come PNG Salva come JPEG
Nome #
Cognitive Remediation Therapy (CRT): presupposti e descrizione. 437
Exome sequencing in schizophrenic patients with high levels of homozygosity identifies novel and extremely rare mutations in the GABA/glutamatergic pathways 242
Il training cognitivo nei pazienti affetti da schizofrenia 168
Predictors of cognitive improvement and normalization under cognitive remediation in patients with schizophrenia. 163
The impairment of GABAergic pathway as one of the driver forces in the etiopathogenesis of schizophrenia: evidence from functional studies and gene-set enrichment analyses 158
Italian Study on Depressive Disorders (STudio Italiano MAlattia Depressiva, or STIMA-D): a nationwide snapshot of the status of treatment for major depression. 149
The Effect of Antipsychotic Treatment on Cortical Gray Matter Changes in Schizophrenia: Does the Class Matter? A Meta-analysis and Meta-regression of Longitudinal Magnetic Resonance Imaging Studies 146
Correlates of autistic traits among patients with borderline personality disorder 146
Cognitive remediation in schizophrenia: current status and future perspectives. 145
Interview-based assessment of cognition in schizophrenia: applicability of the Schizophrenia Cognition Rating Scale (SCoRS) in different phases of illness and settings of care. 140
Combined measure of smooth pursuit eye movements and ventricle-brain ratio in schizophrenic disorders. 137
The influence of illness-related variables, personal resources and context-related factors on real-life functioning of people with schizophrenia 136
Psychiatric hospitalization rates in italy before and during covid-19: Did they change? an analysis of register data 135
Does cognitive remediation modify the use of psychiatric services and the patterns of care of patients with schizophrenia? 129
Looking through autistic features in schizophrenia using the PANSS Autism Severity Score (PAUSS) 124
Factors Associated With Response and Resistance to Cognitive Remediation in Schizophrenia: A Critical Review 122
Adult Autism Subthreshold Spectrum (AdAS Spectrum): Validation of a questionnaire investigating subthreshold autism spectrum 121
Categorical and dimensional approaches to negative symptoms of schizophrenia: focus on long-term stability and functional outcome. 120
Effects of cognitive remediation therapy on neurocognition and negative symptoms in schizophrenia: an Italian naturalistic study 120
Psychomotor agitation in subjects hospitalized for an acute exacerbation of Schizophrenia 120
Effectiveness of different modalities of cognitive remediation on symptomatological, neuropsychological, and functional outcome domains in schizophrenia: A prospective study in a real-world setting 119
Psychopathologic, neuropsychological and functional outcome measures during cognitive rehabilitation in schizophrenia: A prospective controlled study in a real-world setting. 118
A genome-wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorder. 117
Hyperprolactinemia in antipsychotic-naive patients with first-episode psychosis. 117
Autism spectrum disorder and schizophrenia: Do they overlap? 116
Autistic traits in a sample of adult patients with schizophrenia: prevalence and correlates 116
X-linked mental retardation with Marfanoid habitus. First report of four italian patients. 114
Factors Associated With Brain Heterogeneity in Schizophrenia 114
Adult ADHD: Prevalence and Clinical Correlates in a Sample of Italian Psychiatric Outpatients 113
Cognitive remediation in schizophrenia. 112
The GRM7 gene, early response to risperidone, and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis 111
Tools for measuring clinical effectiveness. 110
Virological and immunological study of schizophrenic patients in relation to CT scan abnormality. 109
HLA-DR antigens in schizophrenia. 108
Factors affecting antipsychotic drug discontinuation in the treatment of schizophrenia: Evidence from a naturalistic, retrospective, 18-month follow-up study. 107
Age of onset in familial schizophrenia. 106
Season of birth and cerebral ventricular enlargement in schizophrenia 106
A novel homozygous mutation in GAD1 gene described in a schizophrenic patient impairs activity and dimerization of GAD67 enzyme 106
Cognitive remediation in the early course of schizophrenia: a critical review. 105
Non pharmacological strategies to enhance adherence and continuity of care in schizophrenia. 105
Attitudes of Italian Psychiatrists Toward the Evaluation of Physical Comorbidities and Sexual Dysfunction in Patients With Schizophrenia. Implications for Clinical Practice 105
Alpha reactivity in schizophrenia and in schizophrenic spectrum disorders: demographic, clinical and hemispheric assessment. 104
Brain structural abnormalities at the onset of schizophrenia and bipolar disorder: a meta-analysis of controlled magnetic resonance imaging studies 104
The relationships of personal resources with symptom severity and psychosocial functioning in persons with schizophrenia: results from the Italian Network for Research on Psychoses study 104
A roadmap to disentangle the molecular etiology of schizophrenia 103
Adherence to antipsychotics in schizophrenia. 103
Time course of cerebral ventricular enlargement in schizophrenia supports the hypothesis of its neurodevelopmental nature. 103
Brain morphology in schizophrenic disorder: prevalence and correlates of diffuse (cortical and subcortical) brain atrophy. 101
Cognitive remediation in schizophrenia: background, techniques, evidence of efficacy and perspectives 100
Longitudinal studies of brain morphology and outcome of schizophrenic disorder 98
At-risk gambling in patients with severe mental illness. Prevalence and associated features. 98
Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates 98
Evidence for linkage to psychosis and cerebral asymmetry (relative hand skill) on the X chromosome 97
Early life events and affective disorder revisited. 97
Patterns of Structural MRI Abnormalities in Deficit and Nondeficit Schizophrenia. 97
Il rimedio cognitivo nelle psicosi: principi e metodi. 97
Magnetic resonance imaging findings in schizophrenia: relationships with language and thought disorders, symptomatology and cognitive performance. 97
Effectiveness of Cognitive Remediation in Early Versus Chronic Schizophrenia: A Preliminary Report 97
Factors related to different reasons for antipsychotic drug discontinuation in the treatment of schizophrenia: A naturalistic 18-month follow-up study. 96
Lack of evidence for linkage to chromosomes 13 and 8 for schizophrenia and schizoaffective disorder 96
A linkage study of schizophrenia to markers within Xp11 near the MAOB gene. 96
Autistic symptoms predict social cognitive performance in patients with schizophrenia 96
Historical, psychopathological, neurological, and neuropsychological aspects of deficit schizophrenia: a multicenter study. 95
Persistence of effectiveness of cognitive remediation interventions in schizophrenia: A 1-year follow-up study. 95
The effects of antipsychotic treatment on cerebral structure and function in schizophrenia. 95
A reconsideration of the relationship between cerebral structural abnormalities and family history of schizophrenia. 94
Il training cognitivo della Terapia Psicologica Integrata (IPT): presupposti e descrizione. 94
Failure to find a chromosome 18 pericentric linkage in families with schizophrenia 94
Uso della PET e della SPECT in psichiatria 94
Outcome of positive and negative symptoms during neuroleptic therapy in schizophrenia 94
Cognitive remediation in schizophrenia: a controlled study 93
Cerebral ventricular abnormalities in schizophrenia: evidence of their early origin and stability over time. 93
Cortical atrophy in schizophrenia: prevalence and associated features 92
CT scan abnormalities and outcome of chronic schizophrenia 92
Cognitive Remediation Therapy (CRT): presupposti e descrizione. 92
Male siblings with schizophrenia share alleles at the androgen receptor above chance expectation. 92
Gray matter, white matter, brain, and intracranial volumes in first-episode bipolar disorder: a meta-analysis of magnetic resonance imaging studies 92
A genome-wide search for schizophrenia susceptibility genes. 91
Hippocampal and amygdala volume reductions in first-episode schizophrenia. 91
Structural brain abnormalities in bipolar disorder: what meta-analyses tell us 91
Antipsychotic drugs v. barbiturates or benzodiazepines used as active placebos for schizophrenia: a systematic review and meta-analysis 91
Non-selective impairment of Wisconsin Card Sorting Test performance in patients with schizophrenia. 90
Cerebral ventricular enlargement as a generalized feature of schizophrenia: a distribution analysis on 502 subjects. 90
Neuromorphological correlates of mood disorders: focus on cerebral ventricular enlargement. 90
Clinical-biological patterns and prediction of response to haloperidol in schizophrenia 90
Language and thought disorder in schizophrenia: brain morphological correlates. 89
Poor adherence to antipsychotic medication in people with schizophrenia: diffusion, consequences and contributing factors. 89
Personal resources and depression in schizophrenia: The role of self-esteem, resilience and internalized stigma 89
Qualitative MRI findings in patients with schizophrenia: a controlled study. 88
Real-world effectiveness of long acting aripiprazole: Treatment persistence and its correlates in the Italian clinical practice 88
Psychopathological and cognitive features in subclinical hypothyroidism 87
Neurobiological and clinical effect of metacognitive interpersonal therapy vs structured clinical model: study protocol for a randomized controlled trial 87
In vivo serotonin 5HT(2A) receptor binding and personality traits in healthy subjects: a positron emission tomography study. 86
COMT Val(158)Met and BDNF C(270)T polymorphisms in schizophrenia: a case-control study. 86
No evidence for a parent-of-origin effect detected in the pattern of inheritance of schizophrenia. 86
Psychosocial Rehabilitation in Italy Today 86
Stability of cerebral ventricular size from the appearance of the first psychotic symptoms to the later diagnosis of schizophrenia. 86
Brain density patterns in schizophrenia 86
Developmental brain abnormalities in schizophrenia: contributions of genetic and perinatal factors. 85
Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. 85
Totale 11.002
Salva come PNG Salva come JPEG
Categoria #
all - tutte 79.170
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.170
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192.284 0 0 20 25 275 45 266 290 24 272 543 524
2019/20206.570 981 173 175 639 348 752 671 725 450 834 413 409
2020/20214.744 108 578 189 493 180 575 143 526 539 563 597 253
2021/20222.564 185 458 58 149 39 125 121 198 137 284 186 624
2022/20233.211 412 30 31 330 247 802 31 378 569 57 173 151
2023/2024566 212 92 262 0 0 0 0 0 0 0 0 0
Totale 23.601